Copy
Nicotine Science & Policy
September

27
Friday

Follow us on:

Twitter
Facebook

The war against nicotine

It has become a common coffee shop experience to get engaged in discussions concerning opioid and nicotine addictions, given all the frightening stories on overdoses and vaping. We wonder what can possibly be done to reduce the reported harms. After all, as we sip our lattes and cappuccinos; maybe a double espresso if we feel the need, we all have attitudes about addictions. Often, while possibly getting our cup refilled, we acknowledge that we cannot understand what could cause someone to use drugs. [...]

2019-09-27
hospitalnews.com

Why Britain’s apology for e-cigarettes misses the point

Britain and America have been largely in step on regulating tobacco products since the mid-1960s, when they published their first tobacco control laws just months apart from one another. Now, however, a trans-Atlantic split has emerged. After six people died from vaping-related lung diseases in the US, Donald Trump has promised a ban on flavoured e-cigarettes. The UK’s public health chiefs, however, continue to downplay the risks. [...] Martin Dockrell, has said such a ban would be counter-productive since European vaping products are far safer than their US counterparts; [...]

2019-09-27
european-views.com

Health Crisis Casts Shadow Over Canadian Debut of Cannabis Vapes

The vaping health crisis is happening at a very bad time for the Canadian cannabis industry. With pot stocks already down over 40% since the end of the first quarter, news that an Ontario youth has been diagnosed with Canada’s first reported vaping-linked illness while hundreds have fallen ill in the U.S., is further battering the sector. It’s not clear what’s causing the illnesses or whether they’re tied to nicotine, cannabis or both. As long as that uncertainty persists, so will questions about whether the big bets many Canadian pot companies have made on vaping will pay off.

2019-09-27
bloomberg.com

Philip Morris CEO on Altria and the future of e-cigarettes

Philip Morris International CEO Andre Calantzopoulos joins 'Squawk on the Street' to discuss why Philip Morris International ended merger talks with Altria, Juul's future and vapings regulations.

2019-09-27
youtube.com

FDA Panel Votes on OTC Nicotine Mouth Spray for Smoking Cessation

The Nonprescription Drugs Advisory Committee (NDAC) of the Food and Drug Administration (FDA) has recommended the approval of the New Drug Application (NDA) from GlaxoSmithKline for an over-the-counter (OTC) nicotine mouth spray to aid in smoking cessation (9 to 6 vote). The nicotine mouth spray (NMS) delivers 1mg nicotine per spray; each dispenser would deliver at least 140 sprays, with a maximum of 4 sprays per hour and 64 sprays per day. The device includes an actuator press fitted to the spray pump and a press-and-push locking mechanism designed to be child-resistant.

2019-09-27
psychiatryadvisor.com

The Dead End Feeling

States and local governments continue to push bans. Trump also now pushes to ban flavored e-cigarettes which will carry an economic toll. But, most importantly, an emotional one. Vape shop owners now assess the coming damage by making advanced plans to close their doors and layoff employees. The following is a dispatch from my travels across the United States. As I traveled to Washington, D.C. for the Global Tobacco and Nicotine Forum, my mind was unsettled. This is what happened, who I spoke to, and where my mind was in the days leading up to my arrival in D.C.

2019-09-27
vapingpost.com

++++++ For more news, visit https://nicotinepolicy.net ++++++






This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
Nicotine Science and Policy · c/o Knowledge-Action-Change · 8 Northumberland Avenue · London, WC2N 5BY · United Kingdom